Contrast-Enhanced Cardiovascular Magnetic Resonance Imaging

Topics in Magnetic Resonance Imaging

Volumn 14, Issue 5, 2003, Pages 386-402

  Schneider, Günther ^a   Ahlhelm, Frank ^a   Seidel, Roland ^a   Fries, Peter ^b   Kramann, Bernhard ^a   Böhm, Michael ^a   Kindermann, Ingrid ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Building 49 ^*

Author keywords

Cardiac imaging; Contrast enhanced MRI; Ischemic heart disease; Pulmonary vasculature; Thoracic aorta

Indexed keywords

DOBUTAMINE; GADOBENIC ACID; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ACUTE HEART INFARCTION; AMYLOIDOSIS; CARDIOVASCULAR DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; FUNCTIONAL ASSESSMENT; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; LUNG BLOOD VESSEL; MAGNETIC RESONANCE ANGIOGRAPHY; MUSCULAR DYSTROPHY; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDITIS; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; THORACIC AORTA;

AORTA, THORACIC; CONTRAST MEDIA; CORONARY VESSELS; HEART; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; MYOCARDITIS; MYOCARDIUM; PERICARDITIS; PULMONARY EMBOLISM;

EID: 0347504944     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200310000-00005     Document Type: Review

References (24)

1. Lerner DJ, Kannal WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow up of the Framingham population. Am Heart J. 1986;111:383-390.
2. American Heart Association. Heart and Stroke Facts. Dallas, TX: American Heart Association, 1992:1-2.
3. Rivas F, Cobb FR, Bache RJ, et al. Relationship between blood flow to ischemic regions and extent of myocardial infarction: serial measurement of blood flow to ischemic regions in dogs. Circ Res. 1976;38:439-447.
4. Harris PJ, Harrel FE, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259-1269.
5. Mock MB, Ringquist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation. 1982;66:562-568.
6. Picano E, Sicari R, Landi P, et al. Prognostic value of myocardial viabilità in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation. 1998;98:1078-1084.
7. Bolli R. Mechanism of myocardial stunning. Circulation. 1990;83:723-738.
8. Marholdt H, Wagner A, Judd RM, et al. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J. 2002;23:602-619.
9. Anselmi M, Golia G, Cicoira M. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol. 1998;81:21-28.
10. Zerhouni EA, Parish DM, Rogers WJ, et al. Human heart: tagging with MR imaging-a method for non-invasive assessment of myocardial motion. Radiology. 1988;12:220-222.
11. Mallory GK, White PD, Salcedo-Galger J. The speed of healing of myocardial infarction: a study of the pathologic anatomy in 72 cases. Am Heart J. 1939;18:647-671.
12. Baer FM, Voth E, LaRosee K, et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol. 1996;78:415-419.
13. Wisenberg G, Prato FS, Carrroll SE. Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion. Am Heart J. 1988;115:510-518.
14. Van Djikman PR, Van der Wall EF, De Roos A, et al. Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology. 1991;180:147-151.
15. Kim RJ, Judd RM, Chen EL, et al. Relationship of elevated 23 Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. Circulation. 1999;100:185-192.
16. Ramani K, Judd RM, Holly TA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary heart disease and left ventricular dysfunction. Circulation. 1998;98:2687-2694.
17. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance image of 2-day-old reperfused canine infarcts. Circulation. 1995;92:1902-1910.
18. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation. 2002;105:162-167.
19. Paydarfar D, Krieger D, Dib N, et al. In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: distinct features of subacute thrombi. Cardiology. 2001;95:40-47.
20. Gerber BL, Garot J, Bluemke DA, et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 2002;106:1083-1089.
21. Laissy JP, Messin B, Varenne O, et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest. 2002;122:1638-1648.
22. Sechtem U, Tscholakoff D, Higgins CB. MRI of the normal pericardium. AJR Am J Roentgenol. 1986;147:245-252.
23. Watanabe A, Hara Y, Hamada M, et al. A case of effusive-constrictive pericarditis: an efficacy of Gd-DTPA enhanced magnetic resonance imaging to detect a pericardial thickening. Magn Reson Imaging. 1998;16:347-350.
24. Prince MR. Gadolinium-enhanced MR aortography. Radiology. 1994;191:155-164.